Learning objectives:

1.  Briefly review pharmacology, mechanism of action of hydroxychloroquine. 

2. Review the literature regarding hydroxychloroquine dose reduction and effect on disease activity in SLE. 

3. Propose and discuss feasibility of study based on our own experience with hydroxychloroquine dose reduction in setting of new AAO guidelines. 

3031 Duke South
Durham, NC 27701
United States
Session date: 
05/29/2018 - 8:00am to 9:00am EDT

Please login or register to take this course.
Speaker Name: 
Dr. Jon Golenbiewski